NHS National Pharmaceuticals Transition 2022_1

Published date: 17 March 2022

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.

Closing: 21 April 2022, 1pm

Contract summary

Industry

Pharmaceutical products - 33600000

Location of contract

East Midlands, East of England, London, North East, North West, South East, South West, West Midlands, Yorkshire and the Humber, Channel Islands, Isle of Man

Value of contract

£159,010,000 to £1

Procurement reference

CF-0710400D0O000000rwimUAA1

Published date

17 March 2022

Closing date

21 April 2022

Closing time

1pm

Contract start date

29 July 2022

Contract end date

31 May 2024

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Description

Invitation to offer for NHS National Pharmaceuticals Transition 2022_1
Offer reference number: CM/PHG/21/5637
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.
Potential periods of call-offs under the framework agreement:

Transition: CESW: 29/07/2022 to 30/09/2023 (14 months)
LSNE: 29/07/2022 to 31/05/2024 (22 months)
NWLN: 29/07/2022 to 31/01/2023 (6 months)

Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22 months)

Hospital Only Products: CESW: 29/07/2022 to 30/09/2023 (14 months)
LSNE: 29/07/2022 to 31/05/2024 (22 months)
NWLN: 29/07/2022 to 31/01/2023 (6 months)

More information

Links

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2f/_J5KU.TO3C01GXtTb59L7AfJ_oCOSi5PHKU_T70zVqg
Document No. 03 - Framework Agreement and Terms and Conditions

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2p/Eng2.ORgPz.XA50ZZoiB2DPcJ1P4A.TO4tz2kthw95w
Document No. 05a(i) Product Listing and usage Transition CM_PHG_21_5637_00

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2G/_4YZMvnFYqEzphU46LVoo8GAnm6taHFJD3OFDe9aAjs
Document No. 04 - Contract technical specification

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2k/QyHWHOmm3s7M4OM9DVVPlxwPtjUXjGNDelWUEOwfkIU
Document No. 05a(v) Product Listing and Usage Hospital only Products CM_PHG_21_5637_02

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2o/HndL4pvBUmOWROvV28cEiRPX5rHYtfonRVMgI6y2kf0
Document No. 05b - Selectt offer schedule instructions

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2j/A9.eKbRY5JwiPURdwaT3hbrEG49lEL90K5R6e5ijwoc
Document No. 05a (ii), 05a (iv), 05a (vi) CM_PHG_17_5532 SELECTT Application

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2n/so017jhuxywIWlKdR6PNFM9WklE7Im3B6Xmk9z.rdfA
Document No. 00 - Read Me First Document

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2s/nD3VJF8W.kKloRKR4ReyOpR0Yg_dBX4oCM5z4TiwoLA
Document No. 05a(iii) Product Listing and usage Oral Products plus non-parenterals CM_PHG_21_5637_01

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2e/y87p3nOERZS7UiSzi_7y.EaN0L_Od3NwMnBx98qAgk4
Document No. 01 - Invitation to offer covering letter

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb26/yvqgp3.WSAYPJ57CmRlyHnpKkqAN08.23.nERDLK4CU
Document No. 07a - Quality control technical sheet

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2F/cOg8CjvacGGjuG1OMH5EuBICDrBp5lTrRnl1dscGTwg
Document No. 09 - Stability Data Requirments

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2i/Vjj5x_19ZWuzEG4r1V8sws0YDwiAPgiRt_zHsGagDzg
Document No. 02 - Terms of offer

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2d/hClzb_TqTbdzM9q5xeEeWZBhcICRd14htDXLfdNULUw
Document No. 08 - Confidential information schedule

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb2E/pJ5gOOJGSelwGWyiB.qQKvlIDMxRqr5n_9M.ySxMBLI
Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb24/evB8b8Gkut9SP76SD0jVNTfm83MXFQoIabNgfEGAOd0
Document No. 06 - Form of offer

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Hb25/ebTSPjhvObmcnig4i.7lbWGsT45ss8jcJtQT0zoNRNU
Qualification Questionnaire - Transition 2022_1

About the buyer

Contact name

David Ford

Address

2nd Floor Rutland House
Runcorn
WA7 2ES
UK

Email

david.ford1@nhs.net